These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 25639319)
1. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature. Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319 [TBL] [Abstract][Full Text] [Related]
2. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease. Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells. Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in ACTH-secreting pituitary adenomas. Tani Y; Inoshita N; Sugiyama T; Kato M; Yamada S; Shichiri M; Hirata Y Eur J Endocrinol; 2010 Oct; 163(4):523-9. PubMed ID: 20616110 [TBL] [Abstract][Full Text] [Related]
5. Recurrent gain-of-function USP8 mutations in Cushing's disease. Ma ZY; Song ZJ; Chen JH; Wang YF; Li SQ; Zhou LF; Mao Y; Li YM; Hu RG; Zhang ZY; Ye HY; Shen M; Shou XF; Li ZQ; Peng H; Wang QZ; Zhou DZ; Qin XL; Ji J; Zheng J; Chen H; Wang Y; Geng DY; Tang WJ; Fu CW; Shi ZF; Zhang YC; Ye Z; He WQ; Zhang QL; Tang QS; Xie R; Shen JW; Wen ZJ; Zhou J; Wang T; Huang S; Qiu HJ; Qiao ND; Zhang Y; Pan L; Bao WM; Liu YC; Huang CX; Shi YY; Zhao Y Cell Res; 2015 Mar; 25(3):306-17. PubMed ID: 25675982 [TBL] [Abstract][Full Text] [Related]
6. Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas. Lim JS; Lee MK; Choi E; Hong N; Il Jee S; Kim SH; Lee EJ Endocrine; 2019 Apr; 64(1):147-156. PubMed ID: 30474823 [TBL] [Abstract][Full Text] [Related]
7. Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression. Ruebel KH; Leontovich AA; Jin L; Stilling GA; Zhang H; Qian X; Nakamura N; Scheithauer BW; Kovacs K; Lloyd RV Endocrine; 2006 Jun; 29(3):435-44. PubMed ID: 16943582 [TBL] [Abstract][Full Text] [Related]
8. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease. Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo. Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of neurogenins and NeuroD1 in human pituitary tumours. Fratticci A; Grieco FA; Spilioti C; Giangaspero F; Ventura L; Esposito V; Piccirilli M; Santoro A; Gulino A; Cantore G; Alesse E; Jaffrain-Rea ML J Endocrinol; 2007 Sep; 194(3):475-84. PubMed ID: 17761887 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression of SFRP2 promotes development of the pituitary corticotroph adenoma by upregulating Wnt signaling. Ren J; Jian F; Jiang H; Sun Y; Pan S; Gu C; Chen X; Wang W; Ning G; Bian L; Sun Q Int J Oncol; 2018 Jun; 52(6):1934-1946. PubMed ID: 29620167 [TBL] [Abstract][Full Text] [Related]
13. Targeting the ERK pathway for the treatment of Cushing's disease. Zhang D; Bergsneider M; Wang MB; Heaney AP Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250 [TBL] [Abstract][Full Text] [Related]
14. miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ. Gentilin E; Tagliati F; Filieri C; Molè D; Minoia M; Rosaria Ambrosio M; Degli Uberti EC; Zatelli MC Endocrinology; 2013 May; 154(5):1690-700. PubMed ID: 23525216 [TBL] [Abstract][Full Text] [Related]
15. E2F1-mediated human POMC expression in ectopic Cushing's syndrome. Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805 [TBL] [Abstract][Full Text] [Related]
16. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas. Sekizaki T; Kameda H; Nakamura A; Kuwabara S; Nomoto H; Cho KY; Ishi Y; Motegi H; Miyoshi H; Atsumi T Pituitary; 2023 Oct; 26(5):597-610. PubMed ID: 37642928 [TBL] [Abstract][Full Text] [Related]
17. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037 [TBL] [Abstract][Full Text] [Related]
18. The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion. Zhou YZ; Li CZ; Gao H; Zhang YZ World Neurosurg; 2018 Jun; 114():e329-e337. PubMed ID: 29524699 [TBL] [Abstract][Full Text] [Related]
19. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378 [TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation. Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]